Published in Aliment Pharmacol Ther on October 01, 2001
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
A simple clinical colitis activity index. Gut (1998) 4.35
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology (1992) 2.00
Model of medical treatment for duodenal ulcer. Lancet (1981) 1.98
Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol (1993) 1.94
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut (1977) 1.87
Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut (1976) 1.82
DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology (1992) 1.80
A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther (1996) 1.79
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology (1995) 1.69
Serum -glytamyl transpeptidase activity in liver disease. Gut (1972) 1.69
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.65
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet (1995) 1.58
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.52
Healing of gastric ulcer during treatment with cimetidine. Lancet (1976) 1.52
The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther (1991) 1.51
Helicobacter pylori and gastroduodenal secretory function. Gastroenterology (1996) 1.50
Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol (1995) 1.46
The initial care of newborn infants and subsequent hay fever. Allergy (2000) 1.46
Duodenal ulcers that will not heal. Gut (1984) 1.45
Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol (1998) 1.44
Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) (1991) 1.42
Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther (1991) 1.40
Management issues for debate: the problems in perspective. Aliment Pharmacol Ther (1993) 1.39
Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther (1987) 1.35
A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology (2001) 1.34
Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut (1997) 1.23
Infant mortality and the incidence of inflammatory bowel disease. Lancet (1997) 1.23
Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol (1994) 1.22
Relief of duodenal ulcer sysmptons by oral metiamide. Br Med J (1975) 1.20
Clostridium difficile and inflammatory bowel disease. Gut (1983) 1.20
The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med (1987) 1.18
Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther (1991) 1.17
Letter: Serum lysozyme in inflammatory bowel disease. Lancet (1975) 1.16
Early mucosal changes in Crohn's disease. Gut (1993) 1.16
Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol (1993) 1.15
Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. Gut (1975) 1.15
Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut (1995) 1.10
Value of brush cytology in diagnosis of gastric cancer. Br Med J (1975) 1.09
Mucosal capillary thrombi in rectal biopsies. Histopathology (1992) 1.09
A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther (1998) 1.09
Review article: the pharmacology of rabeprazole. Aliment Pharmacol Ther (1999) 1.09
Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol (1999) 1.08
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther (1990) 1.08
Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther (1994) 1.07
Proceedings: New histamine H2-receptor antagonist inhibits food-stimulated gastric acid secretion. Gut (1975) 1.06
A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther (2005) 1.06
Adult idiopathic pulmonary haemosiderosis and coeliac disease. Q J Med (1981) 1.05
Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology (1995) 1.05
Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology (1999) 1.03
The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Scand J Gastroenterol (1988) 1.01
Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis (1992) 1.00
Thrombotic vascular risk factors in inflammatory bowel disease. Gut (1996) 1.00
Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther (1993) 1.00
Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J Clin Oncol (2002) 1.00
A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Aliment Pharmacol Ther (2002) 1.00
Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut (1997) 0.99
Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol (1998) 0.99
Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut (2003) 0.98
In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. J Med Virol (1997) 0.97
Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol (2000) 0.96
Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Aliment Pharmacol Ther (1993) 0.96
24 hour intragastric acidity during maintenance treatment with ranitidine. Br Med J (Clin Res Ed) (1984) 0.95
Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol. Aliment Pharmacol Ther (1992) 0.95
Histamine H2-receptor antagonists and gastric acid secretion. Pharmacol Ther (1984) 0.94
Pre-ulcerative villous contraction and microvascular occlusion induced by indomethacin in the rat jejunum: a detailed morphological study. Aliment Pharmacol Ther (1995) 0.94
Cyclosporin for Crohn's disease. Lancet (1984) 0.94
Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol (1999) 0.93
Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology (1994) 0.92
Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol (2000) 0.92
Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort. BMJ (1998) 0.92
Medical outpatients: changes that can benefit patients. Clin Med (2004) 0.92
Audit of endoscopic surveillance biopsy specimens in HIV positive patients with gastrointestinal symptoms. Gut (1993) 0.91
Rapid urease test provides specific identification of Campylobacter pylori in antral mucosal biopsies. Postgrad Med J (1988) 0.91
Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology (1991) 0.90
Behavioural techniques in the management of aerophagia in patients with hiatus hernia. J Psychosom Res (1983) 0.90
Management of NSAID induced gastrointestinal disturbance. Ann Rheum Dis (1987) 0.90
Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer. Br Med J (1979) 0.90
Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Aliment Pharmacol Ther (1990) 0.90
Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol (2002) 0.89
Smoking in adults and passive smoking in children are associated with acute appendicitis. Lancet (1999) 0.89
Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci (1991) 0.88
Omeprazole and liver function tests. Lancet (1983) 0.88